Novo Nordisk argues Medicare should negotiate the price for six of its insulin products separately, though they contain the ...

Federal law allows compounding pharmacies to make copies of name brand drugs while there’s a supply shortage. But there's a ...

Independence Health Group, the parent company of Independence Blue Cross, spent $500 million last year to provide weight-control medications to its members.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Even the solid proposals set out by the Trump administration are being undermined by its actions taken elsewhere.

In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

Relief is coming for more than 5 million Medicare beneficiaries who rely on expensive prescription medications.

People who have tried other methods to lose weight have found results from obesity drugs that ‘feel like magic.’ ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

As discussions unfold, Kennedy seeks to balance drug accessibility with concerns about the long-term costs of providing GLP-1 ...